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INTRODUCTION 
Obstructive sleep apnea (OSA) is a common public health concern causing 
metabolic and cardiovascular consequences. Although OSA is a systemic disease, 
the molecular mechanisms and specific genes/proteins associated with such 
processes remain poorly defined. 
AIMS 
To identify dysregulated proteins that could be useful as candidate biomarkers of 
diagnosis/prognosis of OSA. 
METHODS 
Red blood cells (RBC) were collected from peripheral blood of patients with 
moderate/severe OSA (n=12) and snorers (n=12) at pre-(evening) and post-(morning) 
sleep study so that proteome variations between these time points could be assessed. 
RBC samples were randomly pooled (n=4/pool) to constitute 3 biological replicates per 
group of patients and condition. The cytoplasm soluble fraction of RBC was prepared and 
depleted of hemoglobin using HemovoidTM system and then was analyzed by 2-D 
Fluorescence Difference Gel Electrophoresis (2-DIGE) and mass spectrometry (MS). The 
images were acquired in an Imager and analyzed by Progenesis SameSpots software 
(NonLinear version 4.5).  
RESULTS II 
One hundred sixty five protein spots were observed differentially expressed 
(ANOVA p<0.05) in RBC between OSA and Controls at Evening and/or Morning 
(pre- & post-sleep study). 70 spots of these were identified with confidence by 
MS (Matrix-assisted laser desorption/ionization time-of-flight - MALDI-
TOF/TOF). Functional analysis by DAVID Bioinformatics Resources concerning 
biological process (fig A), molecular function (fig B) and cellular component 
indicated that these proteins were mainly cytosolic and associated with 
antioxidant activity and cellular response to stress. Proteoforms of catalase and 
peroxiredoxins-2, subunits of proteasome, ubiquitin proteins, Hsp-70, aldolase-
A and nucleoside diphosphate kinases 1 (NDK) were some of these modulated 
proteins in OSA  (see figures).  
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RESULTS I 
Demographic, polysomnographic and analytical characterization of study sample 
Demographic and PSG parameters Screened Subjects 
  Control (n=12) OSA (n=12) p value 
Age (years) 46.8 (10.0) 45.8 (7.2) NS 
Habits       
  Current Smoking (%) 50% 33.3% NS 
  Current Drinking (%) 58.3% 50% NS 
EPW Score 9.1 (4.3) 9.1 (4.3) NS 
Observational features       
Morning arterial pressure (mmHg) 141.3(23.1)/ 
88.8 (14.6) 
129.8(13.1)/78.9 
(8.3) 
NS 
    BMI (kg/m2) 26.9 (2.5)  30.8 (1.9)  0.003* 
    Abdominal perimeter (cm) 97.5 (6.9) 107.4 (8.6) NS 
Comorbidities       
     Hypertension (%) 41.7% 33.3% NS  
     Respiratory Diseases (%) 16.7 8.3% NS 
     Dyslipidemia (%) 66.7% 83.3% NS  
Polysomnographic parameters       
      RDI (events/hour) 2.7 (1.5) 41.9 (20.5)  3.6E-5* 
      Arousal Index (events/hour) 12.6 (4.8) 34.6 (18.4) 0.001* 
      Minimum Arterial Saturation (%) 88.2 (3.4) 80.5 (7.6) 0.01* 
      T90 (%) 0.1 (0.2) 19.4 (24.6) 0.02* 
      ODI (events/hour) 1.9 (1.4) 36.1 (24.7) 0.0005* 
      Sleep Efficiency (%) 76.7 (14.1) 82.1 (6.8) NS 
CONCLUSION 
• Antioxidant protective function of RBC, involving proteins with circadian rhythms behavior (catalase, peroxiredoxins-2), was dysregulated in OSA patients (specially at evening), 
probably in response to a severe oxidative stress and sleep disturbance. .  
• Proteasome system seemed activated in OSA RBC, suggesting proteostasis imbalance in these cells.   
• NDK, critical in erythroid development, Aldo-A, that is increased in miopathies and Alzheimer, and Hsp70 associated with stress were also found modulated in OSA RBC (evening).  
• The complete identification and validation of these proteins will provide better understanding of OSA pathology that ultimately can be translated into newly effective 
diagnosis/prognosis tools.    
RBC 
Proteomic Workflow 
Values displayed in mean +/- SD  
• Eight CATALASE proteoforms were identified. All of 
them, except spots 581 and 595 - the most basics in 
2D-gel, were significantly down regulated in RBC 
Morning versus RBC Evening, independently of 
disease/health state. 
• However, the proteoform 608 was significantly down 
regulated (ANOVA p < 0.001, fold 1.3) in OSA RBC 
Morning samples in comparison with Controls RBC 
Morning samples. Although not significant, the 
proteoforms 596, 606, 609, 605, 602, also were more 
down regulated in OSA RBC Morning in comparison 
with Control RBC Morning samples. 
Analytical parameters Screened Subjects 
  Control (n=12) OSA (n=12) p value 
Glycemic Profile 
Glucose  
(70-110 mg/dl) 
95.2 (8.5) 96.7 (12.0) NS 
Hb A1C  
(4-6%) 
5.7 (0.4) 5.8 (0.4) NS 
Insulin  
(3-25 mU/L) 
11.0 (6.2) 20.6 (12.5) 0.04* 
HOMA-IR  
(≥3.8) 
2.6 (1.6) 5.0 (3.0) 0.04* 
Lipid Profile 
Cholesterol  
(< 190 mg/dl) 
206.2 (44.3) 193 (30.8) NS 
Triglycerides 
 (<150 mg/dl) 
127.3 (69.7) 217.1 (127.7) NS 
Cardiovascular Marker 
Homocysteine  
(3.7-13.9 µmol/L) 
15.6 (4.3) 15.1 (2.9) NS 
Urinary Catecholamines 
Adrenalin 
 (1.7-22.4 µg/24 h) 
14.97 (15.5) 10.8 (9.3) NS 
Nor-Adrenalin   
(12.1-85.5 µg/24 h) 
73.5 (34.0) 74.98 (37.4) NS 
Dopamine 
 (0-498 µg/24 h) 
389.4 (218.4) 367.3 (169.5) NS 
Verification- The preliminary data by western blotting approach 
using antibodies for aldolase and catalase showed  the same 
expression trend, therefore confirming the results previously 
obtained by 2DIGE.  
CE: control evening; CM: control morning; OE:OSA evening; OM: 
OSA morning.  
